AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RHYTHM BIOSCIENCES LTD

0.080

-0.001-1.23%

Volume:15.56K

Turnover:1K

Market Cap:28.31M

PE:-4.52

High:0.080

Open:0.076

Low:0.076

Close:0.081

52wk High:0.280

52wk Low:0.075

Shares:353.87M

Float Shares:188.31M

Volume Ratio:0.05

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.018

EPS(LYR):-0.018

ROE:-276.00%

ROA:-96.19%

PB:7.78

PE(LYR):-4.52

Loading ...

Overview Company News Filings

Rhythm Biosciences Says Gavin Fox-Smith Resigns as Chair

Rhythm Biosciences - Appoints Sue Macleman as Interim Chair Effective Immediately

THOMSON REUTERS

Rhythm Biosciences - Gavin Fox-Smith Resigns as Chair and Non-Executive Director Effective Immediately

THOMSON REUTERS

Rhythm Biosciences Ltd-Board Changes

THOMSON REUTERS

We Think Rhythm Biosciences (ASX:RHY) Needs To Drive Business Growth Carefully

Simply Wall St.

Rhythm Biosciences FY Prelim Loss from Ordinary Activities After Tax Attributable A$5.9 Mln

THOMSON REUTERS

Rhythm Biosciences - no Dividends Paid, Recommended or Declared for Fy2026

THOMSON REUTERS

Rhythm Biosciences Announces Appointment of Non-Executive Directors

Rhythm Biosciences - Appoints Maureen Baker and Carl Stubbings as Non-Executive Directors Effective 27 August 2026

THOMSON REUTERS

Rhythm Biosciences geneType PRS cancer risk test joins CancerIQ platform network

Rhythm Biosciences Ltd-Rhyo Underwriting Update

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/RHY.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.08,"timestamp":1790921520000,"preClose":0.081,"halted":0,"volume":15558,"delay":0,"changeRate":-0.012345679012345689,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":353866857,"eps":-0.0177,"marketStatus":"Market Closed","change":-0.001,"latestTime":"10-02 16:12:00 AEST","open":0.076,"high":0.08,"low":0.076,"amount":1188,"amplitude":0.049383,"askPrice":0.08,"askSize":19999,"bidPrice":0.077,"bidSize":131393,"shortable":3,"etf":0,"ttmEps":-0.0177,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791154800000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.081,"openAndCloseTimeList":[[1790899200000,1790920800000]],"volumeRatio":0.048764,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RHY.AU","preClose":0.081,"auctionPrice":0.08,"auctionVolume":58,"auction":3,"marketStatus":"盘后竞价","timestamp":1790921399183}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-96.19%","roe":"-276.00%","lyrEps":-0.0177,"volumeRatio":0.048764,"shares":353866857,"dividePrice":0,"high":0.08,"amplitude":0.049383,"preClose":0.081,"low":0.076,"week52Low":0.075,"pbRate":"7.78","psRate":"16.26","week52High":0.28,"institutionHeld":0,"latestPrice":0.08,"committee":0.735798,"eps":-0.0177,"divideRate":0,"volume":15558,"delay":0,"ttmEps":-0.0177,"open":0.076,"prevYearClose":0.135,"prevWeekClose":0.082,"prevMonthClose":0.081,"prevQuarterClose":0.081,"fiveDayClose":0.082,"twentyDayClose":0.087,"sixtyDayClose":0.091,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHY.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671227261","title":"Rhythm Biosciences Says Gavin Fox-Smith Resigns as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2671227261","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671227261?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:36","pubTimestamp":1790645812,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Says Gavin Fox-Smith Resigns As ChairSept 29 (Reuters)-Rhythm Biosciences LtdRHY.AX:GAVIN FOX-SMITH RESIGNS AS CHAIR AND NON-EXECUTIVE DIRECTOR EFFECTIVE IMMEDIATELYAPPOINTS SUE MACLEMAN AS INTERIM CHAIR EFFECTIVE IMMEDIATELYFurther company coverage:RHY.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE9X3JYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671334263","title":"Rhythm Biosciences - Appoints Sue Macleman as Interim Chair Effective Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2671334263","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671334263?lang=en_us&edition=fundamental","pubTime":"2026-09-29 06:11","pubTimestamp":1790633482,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUE9X3JYD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671263337","title":"Rhythm Biosciences - Gavin Fox-Smith Resigns as Chair and Non-Executive Director Effective Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2671263337","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671263337?lang=en_us&edition=fundamental","pubTime":"2026-09-29 06:11","pubTimestamp":1790633482,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUE9X3JYD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671263330","title":"Rhythm Biosciences Ltd-Board Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2671263330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671263330?lang=en_us&edition=fundamental","pubTime":"2026-09-29 06:11","pubTimestamp":1790633482,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUE9X3JYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663972019","title":"We Think Rhythm Biosciences (ASX:RHY) Needs To Drive Business Growth Carefully","url":"https://stock-news.laohu8.com/highlight/detail?id=2663972019","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663972019?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:19","pubTimestamp":1787959158,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-rhy/rhythm-biosciences-shares/news/we-think-rhythm-biosciences-asxrhy-needs-to-drive-business-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-rhy/rhythm-biosciences-shares/news/we-think-rhythm-biosciences-asxrhy-needs-to-drive-business-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776865","title":"Rhythm Biosciences FY Prelim Loss from Ordinary Activities After Tax Attributable A$5.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662776865?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:05","pubTimestamp":1787814349,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXF8J94Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776847","title":"Rhythm Biosciences - no Dividends Paid, Recommended or Declared for Fy2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662776847?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:05","pubTimestamp":1787814349,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXF8J94Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276618","title":"Rhythm Biosciences Announces Appointment of Non-Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276618","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276618?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:32","pubTimestamp":1787707975,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Announces Appointment Of Non-Executive DirectorsAug 26 (Reuters)-Rhythm Biosciences LtdRHY.AX:APPOINTMENT OF NON-EXECUTIVE DIRECTORSAPPOINTS MAUREEN BAKER AND CARL STUBBINGS AS NON-EXECUTIVE DIRECTORS EFFECTIVE 27 AUGUST 2026Further company coverage:RHY.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUE9VN2DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662793757","title":"Rhythm Biosciences - Appoints Maureen Baker and Carl Stubbings as Non-Executive Directors Effective 27 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662793757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662793757?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:07","pubTimestamp":1787695629,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUE9VN2DS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640154700","title":"Rhythm Biosciences geneType PRS cancer risk test joins CancerIQ platform network","url":"https://stock-news.laohu8.com/highlight/detail?id=2640154700","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640154700?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:37","pubTimestamp":1780573041,"startTime":"0","endTime":"0","summary":"CancerIQ added Rhythm Biosciences’ geneType Cancer Risk Assessment to its platform, expanding ordering access across a network of more than 60 health systems.The test combines a polygenic risk score with clinical and family history to produce 5-year and lifetime risk estimates across six cancers.The rollout targets patients with prior hereditary cancer testing or risk not fully explained by traditional models, supporting more personalized screening decisions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL4fRhMm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630378848","title":"Rhythm Biosciences Ltd-Rhyo Underwriting Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2630378848","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630378848?lang=en_us&edition=fundamental","pubTime":"2026-04-28 15:24","pubTimestamp":1777361091,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUE59VSBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}